Ligne de temps
Benjamin Vesin
Technicien(ne)
04 juil. 2025
publication
Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.
Lire plus09 déc. 2024
publication
Enhanced hepatitis B virus-specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection.
Lire plus10 juin 2024
publication
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Lire plus07 sept. 2023
publication
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Lire plus29 juil. 2021